In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite

Biomaterials

Volumn 30, Issue 23-24, 2009, Pages 3996-4005

  Shi, Xuetao ^a,b   Wang, Yingjun ^a   Varshney, Rohan R ^b   Ren, Li ^a   Zhang, Feng ^b   Wang, Dong An ^a,b  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b Nanyang Technological University   (Singapore)

Author keywords

Alendronate; Bisphosphate; Controlled release; Mesoporous silica; Osteogenesis; Synovium derived mesenchymal stem cell

Indexed keywords

ALENDRONATE; BISPHOSPHATE; CONTROLLED RELEASE; MESOPOROUS SILICA; OSTEOGENESIS; SYNOVIUM-DERIVED MESENCHYMAL STEM CELL;

ADDITIVES; BIOMATERIALS; CALCIUM; CELL CULTURE; CELLS; HYDROXYAPATITE; HYDROXYLATION; MICROSPHERES;

SILICA;

ALENDRONIC ACID; ALKALINE PHOSPHATASE; CALCIUM; HYDROXYAPATITE; MICROSPHERE; POLYGLACTIN; SILICON DIOXIDE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG RELEASE; ENZYME ACTIVITY; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYNOVIOCYTE;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; DRUG CARRIERS; DURAPATITE; LACTIC ACID; MESENCHYMAL STEM CELLS; MICROSPHERES; OSTEOGENESIS; PHOSPHATIDIC ACIDS; POLYGLYCOLIC ACID; RABBITS; SILICON DIOXIDE; SYNOVIAL MEMBRANE;

EID: 66049130260     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.04.021     Document Type: Article

References (50)

1. Sakaguchi Y., Sekiya I., Yagishita K., and Muneta T. Comparison of human stem cells derived from various mesenchymal tissue: superiority of synovium as a cell source. Arthritis Rheum 52 (2005) 2521-2529
2. Djouad F., Bony C., Häupl T., Uzé G., Lahlou N., Louis-Plence P., et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7 (2005) 1304-1315
3. Koga H., Muneta T., Ju Y.-J., Nagase T., Nimura A., Mochizuki T., et al. Synovial stem cells are regionally specified according to local microenvironment after implantation for cartilage regeneration. Stem Cells 25 (2007) 689-696
4. Fan J.B., Varshney R.R., Ren L., Cai D.Z., and Wang D.A. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng B 15 (2009) 75-86
5. Stresing V., Daubiné, Benzaid I., Mönkkönen H., and Clézardin P. Bisphosphonates in cancer therapy. Cancer Lett 257 (2007) 16-35
6. Fisher J.E., Rogers M.J., Halasy J.M., Luckman S.P., Hughes D.E., Masarachia P.J., et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclasts formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96 (1999) 133-139
7. Kavanagh K.L., Guo K., Dunford J.E., Wu X., Knapp S., Ebetino F.H., et al. The molecular mechanism of nitrogen-containing bisphophonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A 103 (2006) 7829-7834
8. Gun-II I., Sheeraz A.Q., Jennifer K., Harry E.R., and Arun S.S. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25 (2004) 4105-4115
9. von Konch F., Jaquiery C., Kowalsky M., Schaeren S., Alabre C., Martin I., et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26 (2005) 6941-6949
10. Nafea E.H., EI-Massik M.A., EI-Khordagui L.K., Marei M.A., and Khalafallah N.M. Alendronate PLGA microspheres with high loading efficiency for dental applications. J Microencapsul 24 (2007) 525-538
11. Patashnik S., Rabinovich L., and Golomb G. Preparation and evaluation of chitosan microspheres containing bisphosphonates. J Drug Target 4 (1997) 371-380
12. Balas F., Manzano M., Horcajada P., and Vallet-Regi M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 128 (2006) 8116-8117
13. Palazzo B., Iafisco M., Laforgia M., Margiotta N., Natile G., Bianchi C.L., et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater 17 (2007) 2180-2188
14. Boanini E., Gazzano M., Rubini K., and Bigi A. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater 19 (2007) 2499-2502
15. Shi X., Wang Y., Ren L., Gong Y., and Wang D.-A. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm Res 26 (2009) 422-430
16. Vallet-Regí M., Balas F., and Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 46 (2007) 7548-7558
17. Slowing I.I., Trewyn B.G., Giri S., and Lin V.S.Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 17 (2007) 1225-1236
18. Charnay C., Bégu S., Tourné-Péteih C., Nicole L., Lerner D.A., and Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica: drug and release property. Eur J Pharm Biopharm 57 (2004) 533-540
19. Tozuka Y., Ogushi T., and Yamamoto K. Adsorption and entrapment of salicylamide molecules into the mesoporous structure of folded sheets mesoporous material (FSM-16). Pharm Res 20 (2003) 926-930
20. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2 (2008) 889-896
21. Torney F., Trewyn B.G., Lin V.S.Y., and Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2 (2007) 295-300
22. Luckarift H.R., Spain J.C., Naik R.R., and Stone M.O. Enzyme immobilization in a biomimetic silica support. Nat Biotechnol 22 (2004) 211-213
23. Andersson J., Areva S., Spliethoff B., and Lindén M. Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite. Biomaterials 26 (2005) 6827-6835
24. Shi X., Wang Y., Wei K., Ren L., and Lai C. Self-assembly of nanohydroxyapatite in mesoporous silica. J Mater Sci Mater Med 19 (2008) 2933-2940
25. Shi X, Wang Y, Ren L, Zhao N, Gong Y, Wang D-A. Novel mesoporous silica based antibiotic releasing scaffold for bone repair. Acta Biomater, doi:10.1016/j.actbio.2009.01.010.
26. Kuljanin J., Janković I., Nedeljković J., Prstojević D., and Marinković V. Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions. J Pharm Biomed 28 (2002) 1215-1220
27. Yokoyama A., Sekiya I., Miyazaki K., Ichinose S., Hata Y., and Muneta T. In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel. Cell Tissue Res 322 (2005) 289-298
28. Gregory C.A., Gunn W.G., Peister A., and Prockop D.J. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329 (2004) 77-84
29. Hsu F.Y., Chueh S.-C., and Wang Y.J. Microspheres of hydroxyapatite/reconstituted collagen as supports for osteoblast cell growth. Biomaterials 20 (1999) 1931-1936
30. Jabbarzadeh E., Jiang T., Deng M., Nair L.S., Khan Y.M., and Laurencin C.T. Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Biotechnol Bioeng 98 (2007) 1094-1102
31. De Bari C., Dell'Accio F., Karystinou A., Guillot P.V., Fisk N.M., Jones E.A., et al. Biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58 (2008) 240-250
32. Wang D.-A., Williams C.G., Yang F., Cher N., Lee H., and Elisseeff J.H. Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng 11 (2005) 201-213
33. Meyer U., and Wiesmann H.P. Bone and cartilage engineering (2006), Springer, Heidelberg p. 7-43
34. Harada S.I., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349-355
35. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 19 1 (1998) 80-100
36. Russell R.G., and Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again. Bone 25 (1999) 97-106
37. Rodan G.A. Mechanism of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38 (1998) 375-388
38. Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2000) 1508-1514
39. Tsagozis P., Erikssion F., and Pisa P. Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages. Cancer Immunol Immunother 57 (2008) 1451-1459
40. Pandey R., Quinn J.M.W., Sabokbar A., and Athanasou N.A. Bisphosphonate inhibition of bone resorption induced by particulate biomaterial-associated macrophages. Acta Orthop Scand 67 (1996) 221-228
41. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
42. Nieto A., Balas F., Colilla M., Manzano M., and Vallet-Regí M. Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater 116 (2008) 4-13
43. Lao L., Tan H., Wang Y., and Gao C. Chitosan modified poly(l-lactide) microspheres as cell microcarriers for cartilage tissue engineering. Colloid Surf B 66 (2008) 218-225
44. Wang C., Gong Y., Lin Y., Shen J., and Wang D.-A. A novel gellan gel-based microcarrier for anchorage-dependent cell delivery. Acta Biomater 4 (2008) 1226-1234
45. Wang C., Gong Y., Zhong Y., Yao Y., Su K., and Wang D.-A. The control of anchorage-dependent cell behavior within a hydrogel/microcarrier system in an osteogenic model. Biomaterials 30 (2009) 2259-2269
46. Park K., Park J.S., Woo D.G., Yang H.N., Chung H.-M., and Park K.-H. The use of chondrogenic differentiation drugs to induce stem cell differentiation using double bead microsphere structure. Biomaterials 29 (2008) 2490-2500
47. Wang D.-A., Williams C.G., Yang F., and Elisseeff J.H. Enhancing the tissue-biomaterial interface: tissue-initiated integration of biomaterials. Adv Funct Mater 14 (2004) 1152-1159
48. Wang D.-A., Varghese S., Sharma B., Strehin I., Fermanian S., Gorham J., et al. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater 6 (2007) 385-392
49. Li Q., Wang D.-A., and Elisseeff J.H. Heterogeneous-phase reaction of glycidyl methacrylate and chondroitin sulfate: mechanism of ring-opening-transesterification competition. Macromolecules 36 (2003) 2556-2562
50. Borden M., Attawia M., Khan Y., and Laurencin C.T. Tissue engineering microsphere-based matrices for bone repair: design and evaluation. Biomaterials 23 (2002) 551-559